Jan M. Rothman
Experienced in Urothelial Cancer

Dr. Jan M. Rothman

Hematology Oncology
UPMC
UPMC Hillman Cancer Center - Erie
2500 West 12th Street, 
Erie, PA 
On Staff At
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
Experienced in Urothelial Cancer
UPMC
UPMC Hillman Cancer Center - Erie
2500 West 12th Street, 
Erie, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Jan M. Rothman, MD, is a medical oncologist and treats all medical oncology and hematology cases.

Dr. Rothman is rated as an Experienced provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Mantle Cell Lymphoma (MCL), Lung Cancer, Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, and Bone Marrow Aspiration.

His clinical research consists of co-authoring 3 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology Oncology
Licenses
Internal Medicine in PA
Board Certifications
American Board Of Internal Medicine
American Board Of Internal Medicine
Fellowships
Winthrop University Hospital
Hospital Affiliations
Meadville Medical Center
Upmc Hamot
Lecom Health Corry Memorial Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Geisinger
  • HMO
  • POS
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medical Mutual
  • HMO
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
PA Health and Wellness
  • HMO
  • MANAGED MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Univera Healthcare
  • INSURANCE PLAN
  • MEDICARE MAPD
UPMC
  • EPO
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 17 Less Insurance Carriers -

Locations

UPMC Hillman Cancer Center - Erie
2500 West 12th Street, Erie, PA 16505
Call: 814-836-2600

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Randomized Phase III Trial for Surgically Resected Early Stage Non-small Cell Lung Cancer: Crizotinib Versus Observation for Patients With Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein
A Randomized Phase III Trial for Surgically Resected Early Stage Non-small Cell Lung Cancer: Crizotinib Versus Observation for Patients With Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein
Enrollment Status: Recruiting
Publish Date: July 03, 2024
Intervention Type: Other, Drug
Study Drug: Crizotinib
Study Phase: Phase 3
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Enrollment Status: Active_not_recruiting
Publish Date: December 17, 2025
Intervention Type: Other, Procedure, Biological, Drug
Study Phase: Not Applicable
Randomized Study of Erlotinib Vs Observation in Patients With Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)
Randomized Study of Erlotinib Vs Observation in Patients With Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)
Enrollment Status: Active_not_recruiting
Publish Date: December 04, 2025
Intervention Type: Other, Drug
Study Drug: Erlotinib Hydrochloride
Study Phase: Phase 3
Molecular Analysis for Therapy Choice (MATCH)
Molecular Analysis for Therapy Choice (MATCH)
Enrollment Status: Active_not_recruiting
Publish Date: November 17, 2025
Intervention Type: Procedure, Drug, Other, Biological
Study Drugs: Adavosertib, Afatinib, Binimetinib, Capivasertib, Copanlisib, Crizotinib, Dabrafenib, Dasatinib, Defactinib, Erdafitinib, FGFR Inhibitor AZD4547, Ipatasertib, Larotrectinib, Nivolumab, Osimertinib, Palbociclib, Pertuzumab, PI3K-Beta Inhibitor GSK2636771, Sapanisertib, Sunitinib, Taselisib, Trametinib, Trastuzumab, Ulixertinib, Vismodegib
Study Phase: Phase 2
Adjuvant Nivolumab in Resected Lung Cancers (ANVIL)-A Randomized Phase III Study of Nivolumab After Surgical Resection and Adjuvant Chemotherapy in Non-Small Cell Lung Cancers
Adjuvant Nivolumab in Resected Lung Cancers (ANVIL)-A Randomized Phase III Study of Nivolumab After Surgical Resection and Adjuvant Chemotherapy in Non-Small Cell Lung Cancers
Enrollment Status: Active_not_recruiting
Publish Date: November 17, 2025
Intervention Type: Procedure, Biological, Other
Study Drug: Nivolumab
Study Phase: Phase 3
View 4 Less Clinical Trials

3 Total Publications

Long-Term Prospective Outcomes of Intensity Modulated Radiotherapy for Locally Advanced Lung Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Long-Term Prospective Outcomes of Intensity Modulated Radiotherapy for Locally Advanced Lung Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Journal: JAMA oncology
Published: June 27, 2024
View All 3 Publications
Similar Doctors
Advanced in Urothelial Cancer
Dr. Shinoj P. Pattali-Jayavalsan
Hematology Oncology | Hematology | Oncology
Advanced in Urothelial Cancer
Dr. Shinoj P. Pattali-Jayavalsan
Hematology Oncology | Hematology | Oncology

Ashtabula County Medical Center

2420 Lake Ave, 
Ashtabula, OH 
 (37.2 miles away)
440-997-6969
Languages Spoken:
English, Burmese, Malayalam
See accepted insurances
Accepting New Patients
Offers Telehealth

Shinoj Pattali-Jayavalsan is a Hematologist Oncology specialist and a Hematologist in Ashtabula, Ohio. Dr. Pattali-Jayavalsan is rated as a Distinguished provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Iron Deficiency Anemia, Saddle Pulmonary Embolism, Childhood Iron Deficiency Anemia, Familial Colorectal Cancer, and Bone Marrow Aspiration. Dr. Pattali-Jayavalsan is currently accepting new patients.

Advanced in Urothelial Cancer
Dr. Jason W. Brown
Hematology Oncology | Hematology
Advanced in Urothelial Cancer
Dr. Jason W. Brown
Hematology Oncology | Hematology

Meadville Medical Center

16792 Conneaut Lake Rd, 
Meadville, PA 
 (34.6 miles away)
814-373-2335
Languages Spoken:
English
See accepted insurances

Jason Brown is a Hematologist Oncology specialist and a Hematologist in Meadville, Pennsylvania. Dr. Brown is rated as a Distinguished provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Small Cell Lung Cancer (SCLC), Inflammatory Breast Cancer, Paget Disease of the Breast, and Pleuropulmonary Blastoma.

Advanced in Urothelial Cancer
Dr. Jairus T. Ibabao
Hematology Oncology | Oncology | Hematology
Advanced in Urothelial Cancer
Dr. Jairus T. Ibabao
Hematology Oncology | Oncology | Hematology

Rpci Oncology, PC

21 Porter Ave, 
Jamestown, NY 
 (45.2 miles away)
716-664-1909
Languages Spoken:
English
See accepted insurances

Jairus Ibabao is a Hematologist Oncology specialist and an Oncologist in Jamestown, New York. Dr. Ibabao is rated as a Distinguished provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Paget Disease of the Breast, Pleuropulmonary Blastoma, Chronic Lymphocytic Leukemia (CLL), and Lung Cancer.

VIEW MORE UROTHELIAL CANCER DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Rothman's expertise for a condition
ConditionClose
    • Distinguished
    • Childhood Iron Deficiency Anemia
      Dr. Rothman is
      Distinguished
      . Learn about Childhood Iron Deficiency Anemia.
      See more Childhood Iron Deficiency Anemia experts
    • Chronic Lymphocytic Leukemia (CLL)
      Dr. Rothman is
      Distinguished
      . Learn about Chronic Lymphocytic Leukemia (CLL).
      See more Chronic Lymphocytic Leukemia (CLL) experts
    • Hemangioma Thrombocytopenia Syndrome
      Dr. Rothman is
      Distinguished
      . Learn about Hemangioma Thrombocytopenia Syndrome.
      See more Hemangioma Thrombocytopenia Syndrome experts
    • Iron Deficiency Anemia
      Dr. Rothman is
      Distinguished
      . Learn about Iron Deficiency Anemia.
      See more Iron Deficiency Anemia experts
    • Lung Adenocarcinoma
      Dr. Rothman is
      Distinguished
      . Learn about Lung Adenocarcinoma.
      See more Lung Adenocarcinoma experts
    • Lung Cancer
      Dr. Rothman is
      Distinguished
      . Learn about Lung Cancer.
      See more Lung Cancer experts
    View All 14 Distinguished Conditions
    • Advanced
    • Acute Myeloblastic Leukemia with Maturation
      Dr. Rothman is
      Advanced
      . Learn about Acute Myeloblastic Leukemia with Maturation.
      See more Acute Myeloblastic Leukemia with Maturation experts
    • Acute Myeloblastic Leukemia without Maturation
      Dr. Rothman is
      Advanced
      . Learn about Acute Myeloblastic Leukemia without Maturation.
      See more Acute Myeloblastic Leukemia without Maturation experts
    • Acute Myeloid Leukemia (AML)
      Dr. Rothman is
      Advanced
      . Learn about Acute Myeloid Leukemia (AML).
      See more Acute Myeloid Leukemia (AML) experts
    • Agranulocytosis
      Dr. Rothman is
      Advanced
      . Learn about Agranulocytosis.
      See more Agranulocytosis experts
    • ALK-Positive Non-Small Cell Lung Cancer
      Dr. Rothman is
      Advanced
      . Learn about ALK-Positive Non-Small Cell Lung Cancer.
      See more ALK-Positive Non-Small Cell Lung Cancer experts
    • Anemia
      Dr. Rothman is
      Advanced
      . Learn about Anemia.
      See more Anemia experts
    View All 34 Advanced Conditions
    • Experienced
    • Acute Monoblastic Leukemia (AmoL)
      Dr. Rothman is
      Experienced
      . Learn about Acute Monoblastic Leukemia (AmoL).
      See more Acute Monoblastic Leukemia (AmoL) experts
    • Acute Mountain Sickness
      Dr. Rothman is
      Experienced
      . Learn about Acute Mountain Sickness.
      See more Acute Mountain Sickness experts
    • Acute Myelomonocytic Leukemia
      Dr. Rothman is
      Experienced
      . Learn about Acute Myelomonocytic Leukemia.
      See more Acute Myelomonocytic Leukemia experts
    • Adult Soft Tissue Sarcoma
      Dr. Rothman is
      Experienced
      . Learn about Adult Soft Tissue Sarcoma.
      See more Adult Soft Tissue Sarcoma experts
    • Alveolar Soft Part Sarcoma
      Dr. Rothman is
      Experienced
      . Learn about Alveolar Soft Part Sarcoma.
      See more Alveolar Soft Part Sarcoma experts
    • Anal Cancer
      Dr. Rothman is
      Experienced
      . Learn about Anal Cancer.
      See more Anal Cancer experts
    View All 105 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

        Close
        0 / 1000

        Please provide us with the below insurance information:

                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.